Peptides

HGH 176-191

HGH Fragment 176-191 is a modified peptide derived from the fat-burning region of Human Growth Hormone (HGH). It is widely researched for its potential to support lipolysis (fat breakdown), inhibit fat storage, and assist body recomposition without the growth-promoting effects associated with full HGH. Commonly studied for targeted fat-loss and metabolic support protocols.

  • ✔ High purity research-grade compound
  • ✔ Laboratory tested quality assurance
  • ✔ Secure packaging & global standards
Contact for Inquiry

Product Description

HGH Fragment 176-191

HGH Fragment 176-191, also known as HGH Frag 176-191, is a synthetic peptide consisting of amino acids 176 through 191 from the C-terminal region of Human Growth Hormone (HGH). Researchers identified this specific sequence as the section primarily responsible for HGH’s fat-metabolizing and lipolytic activity.

Unlike full-length HGH, HGH Fragment 176-191 is designed to focus mainly on fat metabolism pathways while minimizing many of the growth-related or IGF-1 elevating effects commonly associated with traditional growth hormone. This selective mechanism has made it one of the most researched peptides in body recomposition and metabolic-focused protocols.

Research suggests that HGH Fragment 176-191 works by stimulating lipolysis — the breakdown of stored fat into usable energy — while simultaneously helping reduce lipogenesis, the formation of new fat cells. Studies indicate it may activate pathways involving cAMP, hormone-sensitive lipase (HSL), and adipose triglyceride lipase (ATGL), helping mobilize stored fatty acids from adipose tissue.

The peptide has gained popularity in research related to:

  • Fat metabolism and body recomposition
  • Stubborn body fat reduction
  • Weight management research
  • Metabolic optimization studies
  • Cutting and conditioning protocols
  • Lipolytic peptide research

One of the major reasons HGH Fragment 176-191 has received attention is because available research suggests minimal impact on blood glucose, insulin sensitivity, and IGF-1 levels compared to traditional HGH.

HGH Frag 176-191 is also commonly associated with the peptide analog AOD-9604, a modified derivative developed specifically for obesity and metabolic research applications.

Key Features

  • Advanced fat-loss research peptide
  • Studied for lipolysis and fat metabolism
  • Non-growth promoting HGH fragment
  • Research focus on body recomposition
  • Investigated for metabolic support applications
  • Minimal IGF-1 activity compared to full HGH

Research Use Notice

This product is intended strictly for laboratory and research purposes only. It is not approved for human consumption or medical use.